01/19/2021
3:02 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2021
6:31 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2021
10:43 AM | Atara Biotherapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
| Form SC 13G
| |
12/18/2020
5:35 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2020
5:32 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4/A
| |
12/09/2020
4:08 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2020
4:07 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
12/07/2020
3:28 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
12/07/2020
7:26 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2020
3:08 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/18/2020
3:07 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2020
3:07 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2020
3:19 PM | Atara Biotherapeutics (Issuer)
Atara Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2020
3:41 PM | Atara Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/09/2020
3:11 PM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2020
3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2020
6:39 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2020
6:38 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2020
6:37 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2020
3:18 PM | Atara Biotherapeutics (Issuer)
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
8:15 PM | Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:46 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:46 PM | Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:45 PM | Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:44 PM | Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:43 PM | Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2020
4:27 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
05/20/2020
5:11 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
5:11 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2020
5:10 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
6:17 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2020
6:16 PM | Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2020
6:44 PM | Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2020
6:43 PM | Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/30/2020
4:25 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/21/2020
3:17 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2020
3:16 PM | Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/07/2020
3:21 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2020
7:46 AM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
02/27/2020
6:47 AM | Atara Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2020
6:35 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2020
7:53 PM | Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2020
7:50 PM | Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/10/2020
6:48 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2020
6:47 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2020
10:26 AM | Atara Biotherapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A
| |
01/28/2020
3:31 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2019
6:51 AM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2019
6:40 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2019
3:12 PM | Atara Biotherapeutics (Subject)
BRIDGER MANAGEMENT, LLC (Filed by)
| Form SC 13G
| |
10/25/2019
4:16 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2019
3:25 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2019
9:20 AM | Atara Biotherapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A
| |
08/08/2019
6:51 AM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2019
6:40 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2019
1:27 PM | Atara Biotherapeutics (Subject)
Camber Capital Management LP (Filed by)
| Form SC 13G
| |
07/22/2019
4:15 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2019
4:25 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
07/18/2019
3:07 PM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
07/01/2019
4:58 PM | Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2019
4:01 PM | Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2019
4:00 PM | Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2019
4:00 PM | Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2019
3:59 PM | Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2019
3:58 PM | Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2019
3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2019
3:20 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2019
3:19 PM | Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/05/2019
5:04 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2019
3:16 PM | Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2019
4:00 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2019
7:25 AM | Atara Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2019
7:10 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2019
3:32 PM | Atara Biotherapeutics (Issuer)
Berger Dietmar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2019
3:31 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2019
3:35 PM | Atara Biotherapeutics (Filer)
| Form DEFA14A
| |
04/29/2019
4:36 PM | Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2019
3:19 PM | Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2019
3:33 PM | Atara Biotherapeutics (Issuer)
Kim Mina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
6:22 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2019
3:16 PM | Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
3:16 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4/A
| |
03/27/2019
4:19 PM | Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2019
4:18 PM | Atara Biotherapeutics (Issuer)
Kim Mina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2019
4:18 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2019
4:17 PM | Atara Biotherapeutics (Issuer)
Berger Dietmar (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2019
4:17 PM | Atara Biotherapeutics (Issuer)
Porter Derrell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2019
3:19 PM | Atara Biotherapeutics (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2019
11:59 AM | Atara Biotherapeutics (Filer)
| Form CT ORDER
| |
03/05/2019
5:58 PM | Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2019
3:09 PM | Atara Biotherapeutics (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2019
3:08 PM | Atara Biotherapeutics (Issuer)
MARCUS JOEL S (Reporting)
| Form 4/A
| |
02/26/2019
7:55 AM | Atara Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2019
7:52 AM | Atara Biotherapeutics (Filer)
| Form 424B5
| |
02/26/2019
7:47 AM | Atara Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2019
6:41 AM | Atara Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2019
9:14 AM | Atara Biotherapeutics (Subject)
Camber Capital Management LP (Filed by)
| Form SC 13G/A
| |
02/14/2019
6:53 AM | ArrowMark Colorado Holdings LLC (Filed by)
Atara Biotherapeutics (Subject)
| Form SC 13G/A
| |
02/12/2019
6:18 PM | Atara Biotherapeutics (Issuer)
Ciechanover Isaac E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
